Cyrannus Revolutionizes VC Platform with Investor Access: AI-Powered Discovery, Evaluation, and Liquidity Opportunities.

Connect Biopharma Holdings has a cash burn of $39m and $72m in cash reserves, giving it a cash runway of around 22 months. The company's cash burn has increased by 76% in the last year, and operating revenue has decreased by 92%. It is unclear if the company will be able to raise more capital through debt or equity to sustain its operations.